Filter
408
Filtered Results: 408
Text search:
M.
Mac
Donald
Featured
Recommendations
35
New Publications
69
Language
Document type
No document type
193
Studies & Reports
101
Guidelines
70
Manuals
28
Strategic & Response Plan
6
Training Material
5
Fact sheets
4
Situation Updates
1
Countries / Regions
Global
17
Kenya
11
India
10
Brazil
8
Russia
6
South Africa
5
Latin America and the Carribbean
5
Western and Central Europe
5
Eastern Europe
5
Sierra Leone
4
Liberia
4
Germany
4
Malawi
4
Mozambique
4
Benin
4
Africa
4
Burkina Faso
3
Nigeria
3
Ethiopia
3
Haiti
3
Philippines
3
Nepal
3
Syria
3
Tanzania
3
Thailand
3
Indonesia
3
Ukraine
3
Angola
3
Paraguay
3
USA
2
Ghana
2
Uganda
2
Bangladesh
2
Colombia
2
Myanmar / Burma
2
Chile
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Asia
2
Senegal
1
Mali
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Zimbabwe
1
South Sudan
1
Lebanon
1
China
1
Rwanda
1
Malaysia
1
Sudan
1
Hungary
1
Lesotho
1
Mexico
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
Poland
1
Italy
1
Congo-Brazzaville
1
Tajikistan
1
Moldova
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
Japan
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
69
Public Health
37
Clinical Guidelines
34
Women & Child Health
29
Key Resources
17
Capacity Building
5
Toolboxes
Mental Health
54
COVID-19
47
HIV
33
Disability
30
Planetary Health
30
AMR
18
Caregiver
18
NTDs
18
NCDs
16
TB
15
Ebola
8
Zika
7
Global Health Education
7
Pharmacy
6
Rapid Response
5
Refugee
4
Natural Hazards
3
Health Financing Toolbox
3
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
This guidance document provides basic principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication studies and on WHO risk communication guidelines.
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines ...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
This training module is designed to equip HWs with knowledge and communication skills to build their confidence and support them in their ability to promote acceptance of COVID-19 vaccination among other HWs.
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
International Health and Human Rights (2018) 18:18
Disability awareness, Community, Attitudes, Experts-by-experience
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
Groupe d'étude sur la douleur et les politiques / Centre collaborateur de l'OMS pour les politiques de soulagement de la douleur et de soins palliatifs
Global Health Science and Practice February 2022, https://doi.org/10.9745/GHSP-D-21-00237
Key Findings: Exposure to vaccination information from faith leaders and health facilities was associated with increased likelihood of vaccination uptake. The significant association between exposure to a...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau...
En 2015, murieron 5,9 millones de niños menores de cinco años (1). Las principales causas de muerte en los niños a nivel mundial son la neumonía, la prematuridad, las complicaciones durante el parto, la sepsis neonatal, las anomalías congénitas, las enfermedades diarreicas, las lesiones ...
En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, les anomalies congénitales, la diarrhée, les tra...
BackgroundClimate change is one of the great challenges of our time. The consequences of climate change on exposed biological subjects, as well as on vulnerable societies, are a concern for the entire scientific community. Rising temperatures, heat waves, floods, tornadoes, hurricanes, droughts, fir...
